FAME 2
2012
Fractional flow reserve versus Angiography for Multivessel Evaluation 2
In 888 patients with stable coronary disease and a functionally significant (FFR ≤0.80) stenosis, FFR-guided PCI plus medical therapy reduced death, MI, or urgent revascularisation compared with medical therapy alone.
Result
Efficacy: Death from any cause, nonfatal MI, or urgent revascularisationHR 0.32 (95% CI 0.19-0.53) · P < 0.001
Below 1 favours FFR-guided PCI plus medical therapy, above 1 favours medical therapy alone.
- Absolute difference
- 8.4 points
- NNT
- 12
Absolute difference and NNT are derived from the event rates.
Also reported: Driven by reduction in urgent revascularisation; no significant difference in death or MI at this early timepoint.
- Subtopic
- FFR-guided PCI
- Design
- Multicentre open-label RCT, stopped early for benefit
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ESC 2024 CCSESC/EACTS 2018 RevascularisationACC/AHA 2023 CCDACC/AHA 2021 RevascularisationAHA/ACC 2021 Chest Pain
- Source
- De Bruyne B, et al. N Engl J Med. 2012;367(11):991-1001.doi 10.1056/NEJMoa1205361
Discussion & critique
Composite driven by the softer, unblinded urgent-revascularisation component and the trial stopped early, which can inflate effect size. Established FFR-guided PCI over medical therapy for functionally significant stable lesions.